FDA Authorizes Pfizer’s COVID-19 Vaccine For Kids Ages 5-11

On Friday, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the Pfizer-BioNTech vaccine for use in children ages 5-11 years. 

As reported by The Wall Street Journal: 

The Covid-19 vaccine from Pfizer Inc. […] and BioNTech SE […] was authorized for use in children as young as 5 years old, the first shot that federal health regulators have permitted for them in the U.S. 

The decision by the Food and Drug Administration on Friday for children age 5 to 11 paves the way for one of the last remaining groups in the U.S. to get vaccinated against Covid-19, probably starting within days.